loader image
Sunday, December 21, 2025
71.2 F
McAllen
- Advertisement -

Can weight training protect your brain from dementia?

Translate to Spanish or other 102 languages!

Engaging in more weight training may help lower dementia risk, new research suggests. Image for illustration purposes
- Advertisement -

Regular exercise is a known modifiable risk factor for dementia. 

A new study suggests that weight training may help protect the brains of older adults from dementia.

The benefits of weight training were also observed in those already showing signs of mild cognitive impairment. 

- Advertisement -

As of 2021, researchers estimate that about 57 million people Trusted Source globally were living with dementia â€” a neurological condition that impacts a person’s memory and thinking skills.

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/can-weight-training-protect-brain-dementia-cognitive-decline?slot_pos=article_1&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-04-11&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Heart Association Highlights 2025’s Major Research Findings

In 2025, cardiovascular investigators worldwide reported findings that could help fill important gaps in preventing and managing conditions including high blood pressure, stroke, heart failure, dangerous blood clots and aortic stenosis.

Uniting Experts to Revolutionize Cancer Treatment

More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominant factor in many cancers including bladder, breast, cervical, head and neck and lung.

Early Findings Show Breast Cancer Vaccine Produces Immune Response

Cleveland Clinic released its findings from the first phase of the clinical trial for the preventive breast cancer vaccine. 
- Advertisement -
Ă—